Will Cyclo Therapeutics Inc (CYTH) Stay at the Top of the Healthcare Sector?

Cyclo Therapeutics Inc (CYTH) is around the top of the Healthcare sector according to InvestorsObserver. CYTH received an overall rating of 35, which means that it scores higher than 35% of stocks. Additionally, Cyclo Therapeutics Inc scored a 74 in the Healthcare sector, ranking it higher than 74% of stocks in that sector.

CYTH has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on CYTH!

See Full CYTH Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cyclo Therapeutics Inc Stock Today?

Cyclo Therapeutics Inc (CYTH) stock is higher by 3.75% while the S&P 500 is down -0.19% as of 9:52 AM on Tuesday, Mar 19. CYTH is higher by $0.06 from the previous closing price of $1.60 on volume of 5,774 shares. Over the past year the S&P 500 has risen 30.07% while CYTH is higher by 76.60%. CYTH lost -$1.67 per share the over the last 12 months. Click Here to get the full Stock Report for Cyclo Therapeutics Inc stock.